Photo taken from Dan Goldstaub/LinkedIn
Sep 19, 2024, 11:34
Dan Goldstaub: Lots of progress at ESMO meeting 2024
Dan Goldstaub, Co-Founder of PhaseV, shared on LinkedIn:
“An overwhelming ESMO meeting 2024 ended in Barcelona!
Lots of progress, new treatments, biomarkers and analysis tools.
Not enough tools coordinating all those into a more successful clinical trial, and that is where we, PhaseV, step in!”
Source: Dan Goldstaub/LinkedIn
More posts featuring ESMO24 on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19